Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
M DEVELOPMENT Aktie jetzt für 0€ handeln | |||||
27.06.24 | Carisma Therapeutics Inc.: Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna | 202 | PR Newswire | Development Candidate targets Glypican-3 for the treatment of solid tumors, including hepatocellular carcinoma
Nomination triggers a $2 million milestone payment to Carisma
PHILADELPHIA, June 27... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
---|